Tokyo, July 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058578) titled 'Registry Study on Transcatheter Aortic Valve Implantation' on July 24.
Study Type:
Observational
Primary Sponsor:
Institute - Shiga University of Medical Science
Condition:
Condition - Hospitalized patients who underwent transcatheter aortic valve implantation (TAVI)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study will collect information on patient characteristics, diagnoses, treatment details, and clinical courses during both the acute and chronic phases from medical records (including electronic health records and laboratory data) of hospitalized patients who underwent transcatheter aortic valve implantation (TAVI) in routine clinical practice.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients hospitalized and undergoing transcatheter aortic valve implantation (TAVI)
Key exclusion criteria - Patients considered inappropriate for inclusion in this study due to incomplete or insufficient medical record data, or other reasons at the discretion of the investigators.
Target Size - 500
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 06 Month 02 Day
Date of IRB - 2025 Year 06 Month 06 Day
Anticipated trial start date - 2025 Year 07 Month 24 Day
Last follow-up date - 2030 Year 05 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066979
Disclaimer: Curated by HT Syndication.
